Join the 'AIDS Related Wasting' group to help and get support from people like you.
AIDS Related Wasting News
Related terms: AIDS Related Anorexia, Wasting Syndrome, AIDS Wasting, Anorexia, AIDS-Associated
Posted 28 Oct 2016 by Drugs.com
FRIDAY, Oct. 28, 2016 – Researchers report that a new medication might revolutionize the treatment of HIV patients who don't respond to existing drugs. The intravenous drug, known as ibalizumab, is given every two weeks. It's now in the final stage of research required before drug makers can seek U.S. government approval. "These are sick, vulnerable, desperate patients," said study author Dr. Jacob Lalezari, an assistant clinical professor of medicine at the University of California, San Francisco. "They're in a bind, and this is potentially a lifesaving therapy," said Lalezari, who is also medical director for Quest Clinical Research. The drug targets patients with multi-drug-resistant HIV, meaning they don't respond to many of the medications used to treat the AIDS-causing virus. It's estimated that 10,000 HIV patients in the United States are immune to several drugs, the researchers ... Read more
Posted 5 Jul 2016 by Drugs.com
PHOENIX, July 05, 2016 (GLOBE NEWSWIRE) – Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that the U.S. Food and Drug Administration (FDA) has approved Insys’ dronabinol oral solution, Syndros, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol, a pharmaceutical version of tetrahydrocannabinol ("THC"). Syndros is approved for use in treating anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. Syndros is currently awaiting scheduling by the U.S. Drug Enforcement Administration. "We are very pleased to announce FDA approval of Syndros. We believe that Syndros will be an important new treatment option for patients suffering from the devastating effects of chemothe ... Read more